person

Lidia G.

Country
Poland
Department
NA

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 25 partner sites.

Specializations

Oncology

The investigator participates in clinical programs addressing malignant neoplasms across both solid and hematologic categories.

  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Gastric and Gastroesophageal Junction Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Classical Hodgkin Lymphoma

All oncology studies are conducted at Mtz Clinical Research Powered By Pratia in Warsaw, Poland.

Autoimmune and Inflammatory Diseases

Research efforts target conditions driven by dysregulated immune responses.

  • Generalized Myasthenia Gravis
  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Atopic Dermatitis

The trials explore novel therapeutic approaches for these immune‑mediated disorders.

Neurological and Neurodegenerative Disorders

Focus is placed on diseases affecting the central nervous system and related functional outcomes.

  • Alzheimer’s Disease
  • Parkinson’s disease
  • Multiple Sclerosis
  • Migraine
  • Epilepsy
  • Major Depressive Disorder

Investigations aim to modify disease progression and alleviate neurological symptoms.

Metabolic and Liver Diseases

Clinical work includes metabolic disorders and liver conditions linked to fatty infiltration and fibrosis.

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
  • Non‑alcoholic Steatohepatitis (NASH)
  • Metabolic Dysfunction‑Associated Steatotic Liver Disease

Study designs assess therapeutic impact on glycemic control and hepatic histology.

Cardiovascular and Hypertension

Efforts are directed toward cardiovascular risk reduction and blood‑pressure management.

  • Heart Failure
  • Resistant Hypertension
  • Uncontrolled Hypertension
  • Cardiovascular disease
  • High‑risk cardiovascular events

Trials evaluate novel agents for improving cardiac outcomes and achieving blood‑pressure targets.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.